Proposed H.B. No. 6750
Session Year 2025

AN ACT AUTHORIZING THE STATE TO MANUFACTURE CERTAIN GENERIC DRUGS.

To authorize the state to manufacture certain generic drugs.

Other Bills with Similar Topics

  Drugs 

 

• HB05175 - AN ACT CONCERNING PRESCRIPTION DRUG COSTS.
• HB05208 - AN ACT CONCERNING THE AUTHORITY OF A POLICE OFFICER TO TRANSPORT A PERSON TO AN EMERGENCY ROOM OR A SUBSTANCE ABUSE FACILITY.
• HB05270 - AN ACT PROHIBITING DIRECT-TO-CONSUMER PRESCRIPTION DRUG ADVERTISEMENTS.
• HB05427 - AN ACT PROHIBITING SALES OF KRATOM PRODUCTS TO INDIVIDUALS UNDER TWENTY-ONE YEARS OF AGE.
• HB05485 - AN ACT ESTABLISHING A CAPTIVE INSURANCE COMPANY TO ADMINISTER A BULK PURCHASE AND DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 PRESCRIPTION DRUGS TO QUALIFYING INDIVIDUALS IN THIS STATE TO TREAT OBESITY.
• HB05591 - AN ACT CONCERNING PRESCRIPTION DRUG REIMBURSEMENT RATES TO PHARMACIES.
• HB05687 - AN ACT ESTABLISHING A NEW CRIME OF MURDER FOR THE SUPPLY OF ILLEGAL DRUGS TO A VICTIM OF AN OVERDOSE.
• HB05714 - AN ACT REQUIRING THE PROVISION OF WRITTEN INFORMATION BY PHARMACISTS CONCERNING THE EFFECTS OF MIFEPRISTONE WHEN DISPENSING TO A PATIENT.
• HB06062 - AN ACT PROHIBITING DIRECT-TO-CONSUMER PRESCRIPTION DRUG ADVERTISEMENTS.
• HB06064 - AN ACT REQUIRING PHARMACISTS TO RESPOND TO QUESTIONS ABOUT PRESCRIPTIONS FROM CONSUMERS WITHIN TWENTY-FOUR HOURS.
• HB06097 - AN ACT CONCERNING PRESCRIPTION DRUG DISCOUNT TRANSPARENCY.
• HB06098 - AN ACT RESTORING 2016 MEDICAID PAYMENT RATES FOR MEDICATION ADMINISTRATION.
• HB06380 - AN ACT DECRIMINALIZING THE POSSESSION OF PSILOCYBIN.
• HB06381 - AN ACT REPEALING THE TRUST ACT.
• HB06501 - AN ACT CONCERNING CONSUMER ACCESS TO PHARMACIES.
• HB06609 - AN ACT CONCERNING MINORS EXPERIENCING GENDER DYSPHORIA OR INCONGRUENCE.
• HB06773 - AN ACT ALLOWING TRAINED NURSE'S AIDES AND ASSISTED LIVING AIDES TO ADMINISTER MEDICATION TO NURSING HOME AND ASSISTED LIVING RESIDENTS.
• HB06810 - AN ACT REQUIRING TRANSPARENCY FROM HEALTH CARE ENTITIES THAT RECEIVE PRESCRIPTION DRUG DISCOUNTS.
• HB06858 - AN ACT CONCERNING THE ATTORNEY GENERAL'S RECOMMENDATIONS REGARDING TICKETS, VETERAN OR MILITARY BENEFIT SERVICES, THE STATE CODE OF ETHICS, UMBILICAL CORD BLOOD, THE SOLICITATION OF CHARITABLE FUNDS ACT AND REAL ESTATE LISTING PROVIDERS.
• SB00011 - AN ACT CONCERNING PRESCRIPTION DRUG ACCESS AND AFFORDABILITY.
• SB00150 - AN ACT CONCERNING DRUGS PRESCRIBED TO TREAT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.
• SB00196 - AN ACT LIMITING CHANGES TO PRESCRIPTION DRUG FORMULARIES FOR PSYCHIATRIC PRESCRIPTION DRUGS.
• SB00263 - AN ACT REQUIRING A STUDY OF THE POTENTIAL HEALTH BENEFITS AND RISKS ASSOCIATED WITH THE USE OF KRATOM.
• SB00361 - AN ACT CONCERNING THE ADEQUATE PRESCRIPTION OF PAIN MEDICATION FOR CANCER PATIENTS, PALLIATIVE AND NURSING HOME PATIENTS AND PATIENTS EXPERIENCING CHRONIC INTRACTABLE PAIN.
• SB00430 - AN ACT PROHIBITING CERTAIN CONDUCT CONCERNING DRUGS AND MEDICAL DEVICES USED TO EXECUTE THE DEATH PENALTY.
• SB00435 - AN ACT AUTHORIZING THE STATE TO IMPORT THE ACTIVE INGREDIENTS OF CERTAIN DRUGS.
• SB00438 - AN ACT ESTABLISHING A STATE-WIDE PROGRAM FOR THE SAFE DISPOSAL OF SHARPS IN CONJUNCTION WITH PRESCRIPTION DRUG TAKE BACK DAYS.
• SB00706 - AN ACT PROHIBITING THE SALE OF KRATOM PRODUCTS TO INDIVIDUALS UNDER TWENTY-ONE YEARS OF AGE.
• SB00749 - AN ACT CLASSIFYING XYLAZINE AS A SCHEDULE IV CONTROLLED SUBSTANCE.
• SB00772 - AN ACT CONCERNING OVERSIGHT AND TRANSPARENCY IN THE PRESCRIPTION OF PSYCHOTROPIC DRUGS TO CHILDREN RECEIVING BENEFITS UNDER MEDICAID.